We focus on a number of topic areas identified by state health policy leaders as important to population health.
Keep up with news and updates from the Milbank Memorial Fund. Get the latest from thought leaders, including Christopher F. Koller, president of the Fund.
We publish The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to population health.
The Center for Evidence-based Policy at Oregon Health & Science University is a national leader in evidence-based decision making and policy design.
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
March 1990 (Volume 68)
March 1990 | Duane M. Kirking, Frank J. Ascione, James W. Richards
Pharmaceutical price increases and greater coverage of outpatient prescription medications have stimulated interest in containing drug benefit-program costs. While mail pharmacy services (MPS) may achieve savings through volume purchasing, high usage of generic drugs, and dispensing larger quantities of medication per prescription, efforts are also underway to adapt community-pharmacy-based services to keep costs down in these areas. No controlled studies document a difference in quality between the two types of services. Third-party administrators and benefit managers need to consider factors such as providing information to patients, monitoring drug therapy, dispensing patients’ correct medication, and cost-control incentives when assessing MPS’s role in prescription drug programs.
Author(s): Duane M. Kirking; Frank J. Ascione; James W. Richards
Download the Article
Read on JSTOR
Volume 68, Issue 1 (pages 29–51) Published in 1990
Trends in the Prevalence of Work Disability from 1962 to 1984, and Their Correlates
The Quality of the Last Year of Life of Older Persons
Get the Latest from the Milbank Memorial Fund